After controlling for calendar period and other confounders, use of HAART decreased the risk of Kaposi's sarcoma, systemic NHL, and CNS NHL. Use of HAART also increased Kaposi's sarcoma survival time but not NHL survival time.
No takes yet. Share an insight, caveat, or question.
Pipkin et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: